Investors Strapped Rocket Corcept: Why the Stock Jumped on Wednesday
A pivotal FDA decision sent Corcept Therapeutics stock soaring. This guide explains the news, what it could mean for ...
This guide discusses withdrawal rate decisions for an index fund portfolio in retirement, including portfolio diversification and contingency planning.
23,394 articlesA pivotal FDA decision sent Corcept Therapeutics stock soaring. This guide explains the news, what it could mean for ...
Auna's Q1 2026 earnings signal a mixed yet resilient growth path. This analysis breaks down revenue, margins, and gui...
As earnings season arrives, smart investors are drilling into Transcat's 2026 earnings outlook. This guide breaks dow...
Gold resumes its ascent in 2026, with three ETFs offering distinct risk paths to access the metal. GLD, GLDM, and GDX...
As Uber morphs into a multi-vertical platform, the real question for investors is how quickly it can translate growth...
A focused screen uncovers a small group of high-yielding stocks trading double-digit discounts, offering both steady ...
Qualcomm just outlined a much larger growth plan, signaling a strong bet on AI beyond smartphones. This deep dive exp...
After years of setbacks, Intel appears to be turning a corner on its AI ambitions. This article breaks down what to w...
Trilogy Metals stock tanked after a tepid earnings release, shaking confidence in a company that explores copper, gol...
Investors are weighing the risks and potential rewards as Netflix prepares for its July earnings. This guide breaks d...
The 2026 software stock sell-off has traders buzzing, even as many companies post solid results. Is AI disruption fea...
This week brought a notable pullback in AI hardware names, including CoreWeave. Read a clear, practical look at what ...